Takeda Pharmaceutical Company Ltd
Takeda Pharmaceutical Company Ltd/ US8740602052 /
TAK
|
04.06.2024 22:10:00
|
Zm.
+0,04
|
Wolumen |
Bid02:00:00 |
Ask02:00:00 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
|
13,40USD
|
+0,30%
|
1,81 mln
Obrót: 23,13 mln |
12,90Wolumen Bid: 100 |
13,45Wolumen Ask: 400 |
48,82 mldUSD |
- |
- |
Opis działalności
Located in Osaka, Japan, Takeda (TYO: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine.
Zarząd & Rada nadzorcza
| CEO |
| Christophe Weber |
| Zarząd |
| Costa Saroukos, Akiko Amakawa, Elaine Shannon, Gabriele Ricci, Giles Platford, Julie Kim, Lauren Duprey, Marcello Agosti, Milano Furuta, Mwana Lugogo, Ramona Sequeira, Takako Ohyabu, Teresa Bitetti, Thomas Wozniewski, Yoshihiro Nakagawa |
| Rada nadzorcza |
| Christophe Weber, Costa Saroukos, Dr. Andrew Plump, Emiko Higashi, Ian Clark, Jean-Luc Butel, Koji Hatsukawa, Michel Orsinger, Olivier Bohuon, Yoshiaki Fujimori, Masami Iijima, Steven Gillis, John Maraganore, Miki Tsusaka, Kimberly A. Reed |
Dane firmy
| Nazwa: |
Takeda Pharmaceutical Company Ltd. |
| Adres: |
1-1, Nihonbashi-Honcho 2-Chome,Chuo-ku, Tokyo 103-8668, Japan |
| Telefon: |
+81-3-3278-2306 |
| Fax: |
+81-3-3278-2268 |
| E-mail: |
-
|
| Internet: |
www.takeda.com/ |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
31.03 |
| Free float: |
- |
| Data IPO: |
- |
Kalendarz korporacyjny
|
Tydz. 27 | 01.07.2024
Wypłata Dywidendy
|
